Mostrar o rexistro simple do ítem

dc.contributor.authorOro Ayude, Marcos
dc.contributor.authorSuh Oh, Hae Jin 
dc.contributor.authorSACRISTAN SANTOS, VICTOR 
dc.contributor.authorVázquez Bartolomé, Patricia
dc.contributor.authorFlorez Menendez, Maria Angeles 
dc.date.accessioned2022-03-23T08:54:36Z
dc.date.available2022-03-23T08:54:36Z
dc.date.issued2020
dc.identifier.issn1662-6567
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32595466es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16364
dc.description.abstractNivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated with nivolumab. This patient achieved a complete response and continues treatment without progression signs, supporting the notion that PD-1 inhibition can induce long-term remission and is well tolerated in this type of patient.en
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.meshImmunotherapy*
dc.typeJournal Articlees
dc.authorsophosOro-Ayude, M.;Suh-Oh, H. J.;Sacristan-Santos, V.;Vazquez-Bartolome, P.;Florez, A.
dc.identifier.doi10.1159/000505478
dc.identifier.pmid32595466
dc.identifier.sophos36637
dc.issue.number1es
dc.journal.titleCase Reports in Dermatologyes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Anatomía Patolóxicaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Dermatoloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Oncoloxía médicaes
dc.page.initial37es
dc.page.final41es
dc.rights.accessRightsopenAccess
dc.subject.decsinmunoterapia*
dc.subject.keywordCHUPes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number12es


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Atribución-NoComercial 4.0 Internacional
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAtribución-NoComercial 4.0 Internacional